Amphiregulin, a ligand of the epidermal growth factor receptor (EGFR), was initially identified as a secreted factor in the ERα-positive MCF7 breast cancer cell line [1], and was shown to be estrogen-responsive [2] in these cells. This evidence concerns the gene EGFR and breast cancer.